The role of nicotinic receptors in SARS-CoV-2 receptor ACE2 expression in intestinal epithelia
Open Access
- 28 October 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bioelectronic Medicine
- Vol. 6 (1), 1-9
- https://doi.org/10.1186/s42234-020-00057-1
Abstract
Background: Recent evidence demonstrated that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) propagates in intestinal epithelial cells expressing Angiotensin-Converting Enzyme 2 (ACE2), implying that these cells represent an important entry site for the viral infection. Nicotinic receptors (nAChRs) have been put forward as potential regulators of inflammation and of ACE2 expression. As vagus nerve stimulation (VNS) activates nAChRs, we aimed to investigate whether VNS can be instrumental in affecting intestinal epithelial ACE2 expression. Methods: By using publicly available datasets we qualified epithelial ACE2 expression in human intestine, and assessed gene co-expression of ACE2 and SARS-CoV-2 priming Transmembrane Serine Protease 2 (TMPRSS2) with nAChRs in intestinal epithelial cells. Next, we investigated mouse and human ACE2 expression in intestinal tissues after chronic VNS via implanted devices. Results: We show co-expression of ACE2 and TMPRSS2 with nAChRs and α7 nAChR in particular in intestinal stem cells, goblet cells, and enterocytes. However, VNS did not affect ACE2 expression in murine or human intestinal tissue, albeit in colitis setting. Conclusions: ACE2 and TMPRSS2 are specifically expressed in epithelial cells of human intestine, and both are co-expressed with nAChRs. However, no evidence for regulation of ACE2 expression through VNS could be found. Hence, a therapeutic value of VNS with respect to SARS-CoV-2 infection risk through ACE2 receptor modulation in intestinal epithelia could not be established.Keywords
Other Versions
Funding Information
- KWF Kankerbestrijding (10495)
- Health Holland TKI (LSH16010, LSH17028)
- Horizon 2020 (H2020-MSCA-ITN-2015, H2020-MSCA-ITN-2018)
- Gut Research Services
- Mead Johnson Nutrition
This publication has 49 references indexed in Scilit:
- TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel DiseaseGastroenterology, 2021
- Implications for Neuromodulation Therapy to Control Inflammation and Related Organ Dysfunction in COVID-19Journal of Cardiovascular Translational Research, 2020
- Parameters matter: modulating cytokines using nerve stimulationBioelectronic Medicine, 2020
- Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic systemToxicology Reports, 2020
- Potential fecal transmission of SARS-CoV-2: Current evidence and implications for public healthInternational Journal of Infectious Diseases, 2020
- Tobacco Product Use and Cessation Indicators Among Adults — United States, 2018Mmwr. Morbidity and Mortality Weekly Report, 2019
- Integrating single-cell transcriptomic data across different conditions, technologies, and speciesNature Biotechnology, 2018
- Up-regulation of the human-specific CHRFAM7A gene in inflammatory bowel diseaseBBA Clinical, 2016
- Chronic vagus nerve stimulation in Crohn's disease: a 6‐month follow‐up pilot studyNeurogastroenterology & Motility, 2016
- Cholinergic Pathways in the Lungs and Anticholinergic Therapy for Chronic Obstructive Pulmonary DiseaseProceedings of the American Thoracic Society, 2005